Using tiny particles designed to target cancer-fighting immune cells, Johns Hopkins researchers have trained the immune systems of mice to fight melanoma, a deadly skin cancer.
Lab-Grown, Virus-Free Stem Cells Repair Retinal Tissue in Mice
Investigators at Johns Hopkins report they have developed human induced-pluripotent stem cells capable of repairing damaged retinal vascular tissue in mice.
Permanent Changes In Brain Genes May Not Be So Permanent After All
Cells turn off genes they don't need, by attaching a chemical methyl group to the DNA. Scientists believed methyl groups could only stick to a particular DNA sequence. But, they've found they stick to other sequences in stem cells and brain neurons.
Rock And Rho: Proteins That Help Cancer Cells Groove
Biologists have discovered that low oxygen conditions, which often persist inside tumors, are sufficient to initiate a molecular chain of events that transforms breast cancer cells from being rigid and stationery to mobile and invasive.
Key Found To Restoring 'Exhausted' HIV-Fighting Immune Cells
Researchers have identified a protein that causes loss of function in immune cells combatting HIV. The scientists report that the protein, Sprouty-2, is a promising target for future HIV drug development, since disabling it could help restore the cells' ability to combat the virus.
Podcasts with ICE researchers
- Finding a Cure for Parkinson's Disease with Ted Dawson
- Scientists Convert Blood Cells Back to Embryonic Stem Cell-Like State with Elias Zambidis
- Transforming Skin Cells to Stem Cells with Ted Dawson
- What Anti-Depression Treatments Actually Target In The Brain with Hongjun Song
- Preventing breast cancer spread with Gregg Semenza
Learn about the latest news from Johns Hopkins Medicine.
Stem cell research at Johns Hopkins Medicine
Read stories and watch videos about other stem cell research happening around campus.
Sign up to receive the Johns Hopkins Medicine Science eNewsletter
Keep up with all the scientific discoveries at Johns Hopkins Medicine-sign up to receive our email newsletter (published eight times per year).